Chapter 893 (2/2)

In addition, tincobail, melisandro and Verizon Telecom will cash at least more than $1 billion in the next listing process. In the first half of the year, through these cash reduction, excluding the capital gains tax, westero is expected to get no less than $10 billion.

Then, in the second half of the year, westero will launch a $10 billion corporate bond issuance program.

All together, 20 billion dollars, just finished Simon's plan to hoard money.

In addition, Simon does not intend to completely give up the plan to suppress the Nasdaq market, but the means will be more hidden and do as much as he can.

In fact, all these actions of drawing funds from the market are suppressing.

Smart people always hesitate when they see Simon westrow constantly taking money and rushing into new technology.

Simon let out the wind and soon got a response.

A group of Wall Street giants such as Goldman Sachs and Morgan Stanley and overseas financial giants such as Credit Suisse are very interested in Simon's planned cash out of these shares, but they just hope that the discount can be lower, and Simon will not give up.

However, the two sides soon started formal contacts.

Simon also brought in cersei capital's black rock asset management company, planning to give at least 10% of the shares. After all, as long as the transaction is not too greedy, the buyer's huge profits can be expected as long as it is not too greedy and has been holding fast to cash out at the right time in the future.

Of course, we should not forget our own people.

Simon just told Lawrence Fink that once the half year sales restriction period for buying these stocks had passed, he would sell them all immediately in terms of the market trend.

Maybe it's because many people have received Simon's promise. After the weekend in early February, the NASDAQ index quickly returned to the 2900 point range, and the obstacle of hitting 3000 points basically disappeared, leaving only a matter of time.

The plan to crack down on Nashi was premature in the beginning, and Simon was not depressed. He pushed the other plans of the westero system forward step by step.In any case, in the future, the market value of the enterprises held by the westrow system may fall sharply due to the collapse of the Nasdaq stock index. However, due to sufficient preparation in advance, the real impact will not be too serious, and they can also expand their strength at low cost in the process of market chaos.

February 7, Wednesday.

Just after the AOL stock reduction incident, another news related to the westrow system burst out.

This morning, Gilead science, a start-up pharmaceutical company in foster, San Francisco Bay area, suddenly held a press conference and announced that it had reached a financing plan with westero company with a total amount of 120 million US dollars. According to this, westero company will obtain 4 million shares of Gilead, with a shareholding ratio of 32.8%, becoming the largest shareholder of Gilead.

Gilead science is a listed company. With the release of this news, it is already a few hours in the afternoon on the east coast. The stock price of the company has soared by 17% and its market value has reached US $535 million, but most people are still in a circle.

Gilead.

What is this?

Fortunately, within a few hours after the news was released, the company's information was dug out.

Of course, Gilead took the initiative to let the wind out.

However, after some research, we soon found that the details of this pharmaceutical enterprise established in 1987 are not flattering.

In the eight years since its establishment, Gilead has focused on the research of immune deficiency and antiviral drugs. It has spent nearly US $100 million, but basically achieved nothing. It can only earn a small amount of revenue by outsourcing contracts provided by pharmaceutical giants such as GlaxoSmithKline.

However, it is a miracle that such a company successfully launched its IPO in 1992 and has survived so far.

This is, of course, a superficial message.

Going deeper, the company's behind the scenes connections, such as the youngest former defense secretary in American history, are obviously one of the main reasons Gilead has been able to maintain up to now. In addition, you can find that the biggest reason why westero company took a stake in this enterprise is probably that Gilead is finally going to launch its first new drug.

According to the information provided by FDA, the new drug, named cidofovir, submitted by Gilead for review, is mainly used to treat a kind of cytomegalovirus retinitis caused by AIDS.

What the hell is this?

Eight years after its establishment, it burned hundreds of millions of US dollars to produce such a new drug with non mainstream complications. Although Gilead has a bright future, it can be directly injected intravenously to replace several existing drugs that can only be given by surgical intubation, and it is estimated that it will contribute more than 150 million US dollars to Gilead's revenue every year after its launch, it still has a long way to go, When everyone is so easy to cheat?

Soon someone broke Gilead's lie.

According to the market demand of this drug, it is a miracle to have a revenue of 15 million US dollars after it is launched, not to mention 150 million US dollars per year.

It's all kinds of unreasonable.

In that case, why did Simon westrow spend $120 million on a stake in such a company?

Although we also found that when 120 million people bought more than 30% of Gilead's shares, Simon westero only paid 20% of the share price before the information disclosure, but if the company is worthless, let alone 20% off, even 40% off, it's just the result of a drift.

Is there anything else we don't know?

So all kinds of gossip began to spread.

After careful study, the good doer finally thinks that he has found the key.

Gilead's focus is on AIDS.

Since the 1980s, AIDS has been widely concerned, and soon become the most feared incurable disease in all sectors of the society.

The poor have nothing to do with it, but the rich are eager to overcome it.

This is probably another important reason why Gilead has been able to get research funding all these years.

Simon westero, perhaps just another rich man who has invested in the fight against AIDS.

After all, there is no shortage of money.

Besides, someone is a well-known playboy.

Even if

It's a precaution, isn't it?

So.

Let's break up.

With the influence of the westero system at the present stage, the mainstream media certainly dare not get involved in this kind of evil lace. It's just that some gossip tabloids or gossip websites are blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatantly blatant.

Simon didn't want to make it too public for westrow to take a stake in Gilead, so he specifically refused a phone invitation from Donald Rumsfeld, who was about to take over the post, to personally invite him to attend the signing ceremony.

It's just that I didn't expect that the public opinion would be skewed here, but it's a little sad.There is no shortage of smart people.

If Simon westero really just spent 120 million dollars to buy insurance for himself, he would do it as quietly as possible. How could he let outsiders know? In this case, does it mean another signal, for example, that westrow plans to enter the medical industry?

If that's true, then it's a good time to follow up in private.

The popularity of the Internet has been too high. Now entering the market, not only the risk increases, but also it is difficult to get high-quality investment projects. Relatively speaking, the medical industry is undoubtedly an opportunity to find a new way to follow Simon westero.